NanoViricides, Inc.
AMEX: NNVC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Anil R. Diwan
- Employees
- 7
- Headquarters
- Shelton, United States
- IPO year
- 2005
- Market cap
- $25.0M
- Website
- https://www.nanoviricides.com
Loading NNVC…
Loading profile data…Frequently asked questions about NNVC
What does NanoViricides, Inc. (NNVC) do?
NanoViricides, Inc. operates as a nano-biopharmaceutical entity, specializing in the research, development, and market introduction of pharmaceutical solutions to combat viral infections. The company's robust product pipeline includes a Human Coronavirus Program, specifically engineered to tackle both COVID-19 and various seasonal coronaviruses....
Where does NNVC trade?
NanoViricides, Inc. (NNVC) trades on the New York Stock Exchange American.
What sector is NNVC in?
NanoViricides, Inc. (NNVC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of NanoViricides, Inc.?
Anil R. Diwan is the chief executive officer of NanoViricides, Inc. (NNVC).
Where is NanoViricides, Inc. headquartered?
NanoViricides, Inc. is headquartered in United States.
Does NNVC pay a dividend?
NanoViricides, Inc. (NNVC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NNVC go public?
NanoViricides, Inc. (NNVC) completed its initial public offering in 2005.